These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6264660

  • 1. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW, Figures WR, Colman RF, Morinelli TA, Niewiarowski S, Mills DC.
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [Abstract] [Full Text] [Related]

  • 2. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
    Macfarlane DE, Srivastava PC, Mills DC.
    J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of an ADP receptor mediating platelet activation.
    Colman RW, Figures WR.
    Mol Cell Biochem; 1984 Mar; 59(1-2):101-11. PubMed ID: 6323960
    [Abstract] [Full Text] [Related]

  • 4. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
    Mills DC, Figures WR, Scearce LM, Stewart GJ, Colman RF, Colman RW.
    J Biol Chem; 1985 Jul 05; 260(13):8078-83. PubMed ID: 2989276
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM, Holmsen H.
    Thromb Haemost; 1984 Dec 29; 52(3):333-5. PubMed ID: 6099615
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIa.
    Colman RW, Figures WR, Wu QX, Chung SY, Morinelli TA, Tuszynski GP, Colman RF, Niewiarowski S.
    Trans Assoc Am Physicians; 1986 Dec 29; 99():39-45. PubMed ID: 3603928
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A, Eckly A, Bari N, Léon C, Hechler B, Cazenave JP, Gachet C.
    Thromb Haemost; 2000 Sep 29; 84(3):484-91. PubMed ID: 11019976
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M, Welzel D, Wolf H, Honey A, Kakkar VV.
    Arzneimittelforschung; 1987 Jun 29; 37(6):669-74. PubMed ID: 2822055
    [Abstract] [Full Text] [Related]

  • 15. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN, Colman RF, Colman RW.
    Eur J Biochem; 1996 Mar 15; 236(3):862-70. PubMed ID: 8665907
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
    Hashimoto S, Itoh Y, Kawaguchi A, Mizuno Y, Muraoka M, Tsuchiya M.
    J Cell Physiol; 1987 Dec 15; 133(3):499-506. PubMed ID: 2826498
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave JP, Mannucci PM.
    Thromb Haemost; 1997 May 15; 77(5):986-90. PubMed ID: 9184415
    [Abstract] [Full Text] [Related]

  • 20. Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets.
    Puri RN, Colman RW.
    Arch Biochem Biophys; 1997 Nov 15; 347(2):263-70. PubMed ID: 9367534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.